000 01442 a2200421 4500
005 20250513114230.0
264 0 _c19970617
008 199706s 0 0 eng d
022 _a0006-3223
024 7 _a10.1016/S0006-3223(96)00222-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMazure, C M
245 0 0 _aRecent life stressors and biological markers in newly admitted psychotic patients.
_h[electronic resource]
260 _bBiological psychiatry
_cApr 1997
300 _a865-70 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcute Disease
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aBiomarkers
650 0 4 _aFemale
650 0 4 _aHomovanillic Acid
_xblood
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aMale
650 0 4 _aMethoxyhydroxyphenylglycol
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aPerphenazine
_xtherapeutic use
650 0 4 _aProlactin
_xblood
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aStress, Psychological
_xpsychology
700 1 _aQuinlan, D M
700 1 _aBowers, M B
773 0 _tBiological psychiatry
_gvol. 41
_gno. 8
_gp. 865-70
856 4 0 _uhttps://doi.org/10.1016/S0006-3223(96)00222-3
_zAvailable from publisher's website
999 _c9081949
_d9081949